Filtered By:
Source: Asian Pacific Journal of Cancer Prevention
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 1106 results found since Jan 2013.
Prevalence and Epidemiological Profile of Ameloblastoma in India: A Systematic Review and Meta-Analyses
CONCLUSION: The systematic study indicates a slight male predisposition to ameloblastoma, with a peak incidence in the third decade of life and the mandible as the preferred anatomical site. The solid/multicystic ameloblastoma is the most prevalent histopathologic pattern. More epidemiological research on the prevalence rate of ameloblastoma is required, particularly in India, in an effort to accurately determine the national epidemiological profile of ameloblastoma.PMID:36444570 | DOI:10.31557/APJCP.2022.23.11.3601
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Yoithapprabhunath Thuckanaickenpalayam Ragunathan Srichinthu Keniyan Kumar Dineshshankar Janardhanam Aravindhan Ravi Vidyalakshmi Santhanam Madhavan Nirmal Ramdas Source Type: research
Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization
CONCLUSION: Based on our findings, patients with intermediate-stage HCC who received TACE had a lower median survival time compared to previous studies. However, we identified APRI less than 0.5, tumor size less than 5 cm, and tumor number less than 7 as prognostic factors improving survival time in intermediate-stage HCC patients.PMID:36444608 | DOI:10.31557/APJCP.2022.23.11.3939
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Nakarin Inmutto Natthaphong Nimitrungtawee Tanop Srisuwan Thanate Kattipathanapong Attaporn Jantarangkoon Oranit Puttisri Source Type: research
Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment
CONCLUSIONS: Based on results, the rs1695 polymorphism could not be considered a risk factor for oral cancer.PMID:36444599 | DOI:10.31557/APJCP.2022.23.11.3859
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Ahmadali Baghaei Mohaddeseh Behjati Ali Karimian Source Type: research
Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization
CONCLUSION: Based on our findings, patients with intermediate-stage HCC who received TACE had a lower median survival time compared to previous studies. However, we identified APRI less than 0.5, tumor size less than 5 cm, and tumor number less than 7 as prognostic factors improving survival time in intermediate-stage HCC patients.PMID:36444608 | DOI:10.31557/APJCP.2022.23.11.3939
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Nakarin Inmutto Natthaphong Nimitrungtawee Tanop Srisuwan Thanate Kattipathanapong Attaporn Jantarangkoon Oranit Puttisri Source Type: research
Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment
CONCLUSIONS: Based on results, the rs1695 polymorphism could not be considered a risk factor for oral cancer.PMID:36444599 | DOI:10.31557/APJCP.2022.23.11.3859
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Ahmadali Baghaei Mohaddeseh Behjati Ali Karimian Source Type: research
Prevalence and Epidemiological Profile of Ameloblastoma in India: A Systematic Review and Meta-Analyses
CONCLUSION: The systematic study indicates a slight male predisposition to ameloblastoma, with a peak incidence in the third decade of life and the mandible as the preferred anatomical site. The solid/multicystic ameloblastoma is the most prevalent histopathologic pattern. More epidemiological research on the prevalence rate of ameloblastoma is required, particularly in India, in an effort to accurately determine the national epidemiological profile of ameloblastoma.PMID:36444570 | DOI:10.31557/APJCP.2022.23.11.3601
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Yoithapprabhunath Thuckanaickenpalayam Ragunathan Srichinthu Keniyan Kumar Dineshshankar Janardhanam Aravindhan Ravi Vidyalakshmi Santhanam Madhavan Nirmal Ramdas Source Type: research
Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization
CONCLUSION: Based on our findings, patients with intermediate-stage HCC who received TACE had a lower median survival time compared to previous studies. However, we identified APRI less than 0.5, tumor size less than 5 cm, and tumor number less than 7 as prognostic factors improving survival time in intermediate-stage HCC patients.PMID:36444608 | DOI:10.31557/APJCP.2022.23.11.3939
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Nakarin Inmutto Natthaphong Nimitrungtawee Tanop Srisuwan Thanate Kattipathanapong Attaporn Jantarangkoon Oranit Puttisri Source Type: research
Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment
CONCLUSIONS: Based on results, the rs1695 polymorphism could not be considered a risk factor for oral cancer.PMID:36444599 | DOI:10.31557/APJCP.2022.23.11.3859
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Ahmadali Baghaei Mohaddeseh Behjati Ali Karimian Source Type: research
Full Compliance of Adjuvant Endocrine Therapy Is Associated with Higher Disease-Free Survival in Hormone Receptor-Positive and HER2-Negative Chinese Breast Cancer Patients with First Tumor Recurrence
CONCLUSIONS: Full compliance of aET was quite low in Chinese HR+HER2- BC patients. However, it was associated with a 38.6% lower risk of first tumor recurrence. To search for effective tools to improve the compliance of aET in this population should be stressed.PMID:36308366 | DOI:10.31557/APJCP.2022.23.10.3413
Source: Asian Pacific Journal of Cancer Prevention - October 29, 2022 Category: Cancer & Oncology Authors: Zhensheng Li Yunjiang Liu Yue Li Yuguang Shang Kaiye Du Xiaohui Ji Huina Han Jun Zhang Source Type: research
